Aclaris Therapeutics Vs. Allakos Industry Stock Comparison

Sell

6

ACRS
Aclaris Therapeutics

Last Price:

1.22

Seasonality Move:

4.39%

Sell

40

ALLK
Allakos

Last Price:

1.06

Seasonality Move:

-3.21%

Sell

6

Aclaris Therapeutics (ACRS) is a Sell

Is Aclaris Therapeutics a Buy, Sell or Hold?

The current Aclaris Therapeutics [ACRS] share price is $1.21. The Score for ACRS is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
ACRS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

40

Allakos (ALLK) is a Sell

Is Allakos a Buy, Sell or Hold?

The current Allakos [ALLK] share price is $1.05. The Score for ALLK is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
ALLK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACRS Stock Price Chart

What is Aclaris Therapeutics's stock price today?

The Aclaris Therapeutics share price today is $1.21
The current trend is relatively stagnant and ACRS is experiencing slight buying pressure.

ALLK Stock Price Chart

What is Allakos's stock price today?

The Allakos share price today is $1.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLK is experiencing selling pressure, which indicates risk of future bearish movement.

ACRS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0	Sell
Relative Strength Index (14 RSI):	49.73	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.19 - 1.25)	Sell
Bollinger Bands (100):	(1.07 - 1.27)	Buy

ALLK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.07	Sell
Relative Strength Index (14 RSI):	40.77	Sell
Chaikin Money Flow:	-167026	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.05 - 1.23)	Sell
Bollinger Bands (100):	(0.95 - 2.43)	Sell

ACRS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.21	Sell
20-day SMA:	1.21	Sell
50-day SMA:	1.22	Sell
200-day SMA:	3.67	Sell
8-day EMA:	1.21	Buy
20-day EMA:	1.21	Sell
50-day EMA:	1.25	Sell
200-day EMA:	3.58	Sell

ALLK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.05	Buy
20-day SMA:	1.11	Sell
50-day SMA:	1.26	Sell
200-day SMA:	2.27	Sell
8-day EMA:	1.06	Sell
20-day EMA:	1.11	Sell
50-day EMA:	1.27	Sell
200-day EMA:	2.52	Sell

Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.

Allakos Earnings Growth & ALLK Earnings Dates

Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.02 per share, an increase this year of $0.65 per share, and an increase next year of $0.52 per share.

Aclaris Therapeutics Technical Analysis

	Apr 17	Apr 18	Apr 19	Apr 22	Apr 23	Apr 24	Apr 25	Apr 26	Apr 29	Apr 30
	Apr
	17	18	19	22	23	24	25	26	29	30
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Allakos Technical Analysis

	Apr 17	Apr 18	Apr 19	Apr 22	Apr 23	Apr 24	Apr 25	Apr 26	Apr 29	Apr 30
	Apr
	17	18	19	22	23	24	25	26	29	30
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):